Mersana Therapeutics Inc

XNAS:MRSN

9.58

+0.28 (+3.01%)

4:10:03 PM EDT: $9.58 0.00 (0.00%)

Market Cap (Intraday)	49.25M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$14.2 Million
Adjusted EPS	-$1.54

See more estimates

10-Day MA	$9.74
50-Day MA	$8.33
200-Day MA	$9.66

See more pivots

Mersana Therapeutics Inc Stock, XNAS:MRSN

840 Memorial Drive, Cambridge, Massachusetts 02139

United States of America

Phone: +1.617.498.0020

Number of Employees: 102

http://www.mersana.com

Description

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. The company was founded by Mikhail Papisov in 2001 and is headquartered in Cambridge, MA.